Background The use of blood products early in the resuscitation of bleeding trauma patients
is widely accepted, but made difficult by limited supplies of D− red blood cell (RBC) …

BACKGROUND Traumatic hemorrhage is the leading cause of preventable death. Early in
the resuscitation, only RhD-positive red blood cells are likely to be available, which poses a …

The use of blood products to resuscitate injured and massively bleeding patients in the
prehospital and early in-hospital phase of the resuscitation is increasing. Using group O red …

OBJECTIVE: To define the frequency, risk factors, and outcomes of massive transfusion in
obstetrics. METHODS: The State Inpatient Dataset for New York (1998–2007) was used to …

Background: Whole blood transfusion is associated with benefits including improved
survival, coagulopathy, and decreased transfusion requirements. The majority of whole …

Background and Objectives D‐negative red cells are transfused to D‐negative females of
childbearing potential (CBP) to prevent haemolytic disease of the foetus and newborn …

Background There is an increasing literature demonstrating the benefits of prehospital and
early in‐hospital transfusions. RhD‐positive products might only be available during these …

Background and Objectives Obstetric haemorrhage is associated with increased blood
transfusion, morbidity and health service usage in women. While the use of transfusion in …

Objective To estimate incidence, trends over time, and risk factors for massive blood
transfusions in obstetric patients. A secondary aim was to evaluate transfusion ratios in …

The safest blood transfusion is the one not administered. When a transfusion is needed, it is
important for both physicians and nursing staff to be aware of its potential acute and delayed …